A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Deferasirox (Deferasorox)

an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older. ( 1.1 ) Deferasirox tablets are indicated for the treatment of ....

First FDA approval2005-11-30
Generic availableYes · 17 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$59.7M in CY2024 Part D spend31K claims · 7K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.875/unit
15 NDCs benchmarked, lowest of all strengths.
Average NADAC
$1.28
Across all dosage forms in distribution.
Highest NADAC
$1.64
Range is tight.
Plans with PA
1497 / 329
Substantial PA friction across plans.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Deferasirox used for?

an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older. ( 1.1 ) Deferasirox tablets are indicated for the treatment of ....

Is there a generic for Deferasirox?

Yes. 75 ANDAs filed at FDA, 17 generic manufacturers currently shipping.

How much does my plan pay for Deferasirox?

Across 329 Part D plans, Deferasirox averages $1.28/unit (NADAC). Lowest available: $0.875/unit. Highest in distribution: $1.64/unit.

Is Deferasirox on the FDA shortage list?

No. Deferasirox is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Iron Chelator3 alternatives in D1
01
Deferasirox Oral
Iron Chelator
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Deferiprone
Brand: FERRIPROX
Lowest NADAC
3Generic mfrs
$83.8MCY24 Part D spend
Compare →
03
Deferoxamine
Brand: Deferoxamine
Lowest NADAC
4Generic mfrs
$224,178CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (15 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.